Biomarker Blood Test Shows Cancer Recurrence Months Before CT Scans

Results from a prospective clinical trial showed that a blood test looking at specific biomarkers was able to detect recurrences of lung cancer an average of six months before conventional imaging methods found evidence of recurrence.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News